{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:26:18Z","timestamp":1765887978413},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,16]]},"DOI":"10.1093\/ibd\/izx062","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T17:40:31Z","timestamp":1518802831000},"page":"510-531","source":"Crossref","is-referenced-by-count":21,"title":["Neoplasia and Precursor Lesions of the Female Genital Tract in IBD: Epidemiology, Role of Immunosuppressants, and Clinical Implications"],"prefix":"10.1093","volume":"24","author":[{"given":"Hanna M J L","family":"Hazenberg","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanne K H","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris J J","family":"Mulder","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stijn H","family":"Mom","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, VU University Medical Center, Amsterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ad A","family":"van Bodegraven","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam"},{"name":"Department of Gastroenterology, Geriatrics, Internal and Intensive Care Medicine (Co-MIK), Zuyderland Medical Center, Heerlen-Sittard-Geleen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greetje J","family":"Tack","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam"},{"name":"Department of Gastroenterology and Hepatology, Medical Center Leeuwarden, Leeuwarden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,2,16]]},"reference":[{"key":"key\n\t\t\t\t20180305101522_CIT0001","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMra1403718","article-title":"Cancers complicating inflammatory bowel disease","volume":"372","author":"Beaugerie","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180305101522_CIT0002","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ecco-jcc\/jjv141","article-title":"European evidence-based consensus: inflammatory bowel disease and malignancies","author":"Annese","year":"2015","journal-title":"J Crohn\u2019s Colitis"},{"key":"key\n\t\t\t\t20180305101522_CIT0003","first-page":"87","volume-title":"Global Cancer Statistics, 2012","author":"Torre","year":"2015"},{"key":"key\n\t\t\t\t20180305101522_CIT0004","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kj\u00e6r","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180305101522_CIT0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection","volume":"102","author":"Rodr\u00edguez","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180305101522_CIT0006","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1473-3099(09)70108-2","article-title":"Clinician\u2019s guide to human papillomavirus immunology: knowns and unknowns","volume":"9","author":"Einstein","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180305101522_CIT0007","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/ijc.29971","article-title":"Progression of HPV infection to detectable cervical lesions or clearance in adult women: analysis of the control arm of the VIVIANE study","volume":"138","author":"Skinner","year":"2016","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180305101522_CIT0008","first-page":"623","article-title":"A study of the menopause, smoking, and contraception in women with crohn\u2019s disease","volume":"72","author":"Lichtarowicz","year":"1989","journal-title":"Q J Med"},{"key":"key\n\t\t\t\t20180305101522_CIT0009","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/1751-2980.12247","article-title":"Menstrual cycle, sex hormones in female inflammatory bowel disease patients with and without surgery","volume":"16","author":"Bharadwaj","year":"2015","journal-title":"J Dig Dis"},{"key":"key\n\t\t\t\t20180305101522_CIT0010","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/ajg.2009.760","article-title":"Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies","volume":"105","author":"Pedersen","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180305101522_CIT0011","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study","volume":"108","author":"Jess","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180305101522_CIT0012","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/annonc\/mdn595","article-title":"Cancer risks in Crohn disease patients","volume":"20","author":"Hemminki","year":"2009","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180305101522_CIT0013","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ygyno.2012.07.100","article-title":"Effect of autoimmune diseases on risk and survival in female cancers","volume":"127","author":"Hemminki","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20180305101522_CIT0014","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ijc.30183","article-title":"Inflammatory bowel disease, cancer and medication: cancer risk in the Dutch population based IBDSL cohort","volume":"139","author":"Van Den Heuvel","year":"2016","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180305101522_CIT0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2013.441","article-title":"Drug therapies and the risk of malignancy in Crohn\u2019s disease: results from the TREAT\u2122 registry","volume":"109","author":"Lichtenstein","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180305101522_CIT0016","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ecco-jcc\/jjv032","article-title":"Incidence, management, and course of cancer in patients with inflammatory bowel disease","volume":"9","author":"Algaba","year":"2015","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20180305101522_CIT0017","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/apt.12624","article-title":"Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-\u03b1 therapy in inflammatory bowel disease","volume":"39","author":"Williams","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180305101522_CIT0018","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ajg.2012.89","article-title":"A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180305101522_CIT0019","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1001\/jama.2014.5613","article-title":"Association between tumor necrosis factor-\u03b1 antagonists and risk of cancer in patients with inflammatory bowel disease","volume":"311","author":"Nyboe Andersen","year":"2014","journal-title":"Jama"},{"key":"key\n\t\t\t\t20180305101522_CIT0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/gut.2008.163642","article-title":"Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study","volume":"58","author":"Fidder","year":"2009","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180305101522_CIT0021","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/j.gastro.2013.12.025","article-title":"Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn\u2019s disease","volume":"146","author":"Osterman","year":"2014","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180305101522_CIT0022","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/aje\/kws375","article-title":"Use of azathioprine and the risk of cancer in inflammatory bowel disease","volume":"177","author":"Pasternak","year":"2013","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20180305101522_CIT0023","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/ajg.2009.745","article-title":"Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study","volume":"105","author":"Armstrong","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180305101522_CIT0024","first-page":"1225","article-title":"Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine","volume-title":"Aliment Pharmacol Ther","author":"Fraser","year":"2002"},{"key":"key\n\t\t\t\t20180305101522_CIT0025","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(94)92150-4","article-title":"Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease 83","volume":"343","author":"Connell","year":"1994","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180305101522_CIT0026","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1440-1746.2011.06865.x","article-title":"Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study","volume":"27","author":"Setshedi","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180305101522_CIT0027","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.3748\/wjg.v19.i30.4877","article-title":"Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain","volume":"19","author":"G\u00f3mez-Garc\u00eda","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20180305101522_CIT0028","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.3748\/wjg.v19.i48.9359","article-title":"Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease","volume":"19","author":"Algaba","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20180305101522_CIT0029","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/pds.3621","article-title":"Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies","volume":"23","author":"Beigel","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t20180305101522_CIT0030","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/gutjnl-2015-311079","article-title":"The safety of vedolizumab for ulcerative colitis and Crohn\u2019s disease","volume":"66","author":"Colombel","year":"2017","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180305101522_CIT0031","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1158\/1055-9965.EPI-04-0918","article-title":"Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology","volume":"14","author":"McIntyre-Seltman","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20180305101522_CIT0032","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/CEJ.0b013e3282f75ea1","article-title":"HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy","volume":"17","author":"De Vuyst","year":"2008","journal-title":"Eur J Cancer Prev"},{"key":"key\n\t\t\t\t20180305101522_CIT0033","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/annrheumdis-2013-204993","article-title":"Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study","volume":"74","author":"Kim","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180305101522_CIT0034","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1136\/annrheumdis-2015-208263","article-title":"Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia ? A nationwide study from Sweden","volume":"75","author":"Wadstr\u00f6m","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180305101522_CIT0035","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/AOG.0b013e3181fe777f","article-title":"Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women","volume":"116","author":"Moscicki","year":"2010","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20180305101522_CIT0036","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2036.2004.01858.x","article-title":"Intestinal and extra-intestinal cancer in Crohn\u2019s disease: follow-up of a population-based cohort in Copenhagen county, Denmark","volume":"19","author":"Jess","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180305101522_CIT0037","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.3748\/wjg.v12.i38.6167","article-title":"Abnormalities of uterine cervix in women with inflammatory bowel disease","volume":"12","author":"Bhatia","year":"2006","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20180305101522_CIT0038","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","article-title":"Higher incidence of abnormal pap smears in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180305101522_CIT0039","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1038\/ajg.2009.322","article-title":"Adverse events associated with common therapy regimens for moderate-to-severe Crohn\u2019s disease","volume":"104","author":"Marehbian","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180305101522_CIT0040","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cgh.2014.07.036","article-title":"Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study","volume":"13","author":"Rungoe","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180305101522_CIT0041","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/1097-0142(19861001)58:7<1569::AID-CNCR2820580731>3.0.CO;2-U","article-title":"Colorectal and extracolonic malignancy in ulcerative colitis","volume":"58","author":"Mir-Madjlessi","year":"1986","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180305101522_CIT0042","first-page":"20","article-title":"Crohn\u2019 s disease and cancer risk (Denmark)","author":"Mellemkjaer","year":"2000","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180305101522_CIT0043","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180305101522_CIT0044","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2036.2008.03766.x","article-title":"Screening differences and risk of cervical cancer in inflammatory bowel disease","volume":"28","author":"Hutfless","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180305101522_CIT0045","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/ibd.20959","article-title":"Lack of association between cervical dysplasia and IBD: a large case-control study","volume":"15","author":"Lees","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180305101522_CIT0046","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2008.10.021","article-title":"Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study","volume":"136","author":"Singh","year":"2009","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180305101522_CIT0047","doi-asserted-by":"crossref","first-page":"E711","DOI":"10.1002\/ijc.29209","article-title":"Risk of cervical cancer in women with autoimmune diseases, in relation with their use of immunosuppressants and screening: population-based cohort study","volume":"136","author":"Dugu\u00e9","year":"2015","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180305101522_CIT0048","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MEG.0b013e3282f4489f","article-title":"Liver cirrhosis, other liver diseases, pancreatitis and subsequent cancer: record linkage study","volume":"20","author":"Goldacre","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180305101522_CIT0049","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/MIB.0000000000000338","article-title":"Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia\/cancer? A meta-analysis","volume":"21","author":"Allegretti","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180305101522_CIT0050","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/apt.13215","article-title":"Systematic review and meta-analysis: opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease","volume":"41","author":"Luthra","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180305101522_CIT0051","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jama.283.8.1031","article-title":"Incidence of cervical squamous intraepithelial lesions in HIV-infected women","volume":"283","author":"Ellerbrock","year":"2000","journal-title":"Jama"},{"key":"key\n\t\t\t\t20180305101522_CIT0052","first-page":"97","article-title":"Is HIV infection a cofactor for cervical squamous cell neoplasia","volume":"8","author":"Mandelblatt","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20180305101522_CIT0053","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(14)60920-X","article-title":"Efficacy, safety, and immunogenicity of the human papillomavirus 16\/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study","volume":"384","author":"Skinner","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180305101522_CIT0054","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1071\/SH14015","article-title":"Vaccination against oncogenic human papillomavirus infection in HIV-infected populations: review of current status and future perspectives","volume":"11","author":"Toft","year":"2014","journal-title":"Sex Health"},{"key":"key\n\t\t\t\t20180305101522_CIT0055","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/MIB.0b013e318281341b","article-title":"Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease","volume":"19","author":"Jacobson","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180305101522_CIT0056","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MIB.0000000000000615","article-title":"Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial","volume":"22","author":"Debruyn","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180305101522_CIT0057","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1002\/1097-0142(19851215)56:12<2914::AID-CNCR2820561232>3.0.CO;2-J","article-title":"Extraintestinal cancers in inflammatory bowel disease","volume":"56","author":"Greenstein","year":"1985","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180305101522_CIT0058","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gut.21.12.1024","article-title":"Malignancy in Crohn\u2019s disease","author":"Gyde SN","year":"1980","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180305101522_CIT0059","first-page":"490","article-title":"Cancer morbidity in ulcerative colitis","volume-title":"Gut","author":"Prior","year":"1982"},{"key":"key\n\t\t\t\t20180305101522_CIT0060","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/1097-0142(19910401)67:7<2015::AID-CNCR2820670731>3.0.CO;2-R","article-title":"Extracolonic malignancies in inflammatory bowel disease","volume":"67","author":"Ekbom","year":"1991","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180305101522_CIT0061","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ijc.2910600309","article-title":"Cancer in patients with ulcerative colitis","volume":"60","author":"Mellemkjaer","year":"1995","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180305101522_CIT0062","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/jgh.12189","article-title":"Cancer risk in japanese crohn\u2019s disease patients: investigation of the standardized incidence ratio","volume":"28","author":"Yano","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180305101522_CIT0063","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1097\/MD.0000000000000326","article-title":"PRISMA\u2013efficacy and safety of vedolizumab for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"93","author":"Wang","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20180305101522_CIT0064","volume-title":"New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973\u20132000","author":"Curtis","year":"2006"},{"key":"key\n\t\t\t\t20180305101522_CIT0065","first-page":"742","article-title":"The effect of immunosuppression on pre-existing cancers","volume-title":"Transplantation","author":"Penn","year":"1993"},{"key":"key\n\t\t\t\t20180305101522_CIT0066","doi-asserted-by":"crossref","first-page":"497429","DOI":"10.1155\/2010\/497429","article-title":"Treatment for recurrent ovarian cancer-at first relapse","volume":"2010","author":"Ushijima","year":"2010","journal-title":"J Oncol"},{"key":"key\n\t\t\t\t20180305101522_CIT0067","doi-asserted-by":"crossref","first-page":"410.e1","DOI":"10.1016\/j.ajog.2013.01.047","article-title":"A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia","volume":"208","author":"Gunderson","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20180305101522_CIT0068","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00432-016-2135-2","article-title":"Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16\u2011year period (1998\u20132013): a population-based analysis","volume":"142","author":"Rottman","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"key\n\t\t\t\t20180305101522_CIT0069","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.gastro.2016.03.037","article-title":"Cancer recurrence following immune-suppressive therapies in patients with immune-mediated diseases: a systematic review and meta-analysis","volume":"151","author":"Shelton","year":"2016","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180305101522_CIT0070","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/gutjnl-2013-305763","article-title":"Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer","volume":"63","author":"Beaugerie","year":"2014","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180305101522_CIT0071","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cgh.2015.07.037","article-title":"Risk of new or recurrent cancer in patients with inflammatory bowel disease and previous cancer exposed to immunosuppressive and anti-tumor necrosis factor agents","volume":"14","author":"Axelrad","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180305101522_CIT0072","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/art.39738","article-title":"Association between breast cancer recurrence with immunosuppression in rheumatoid arthritis and inflammatory bowel disease: a cohort study","volume":"68","author":"Mamtani","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t20180305101522_CIT0073","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000353382","article-title":"Use of immunosuppressants and biologicals in patients with previous cancer","volume":"31","author":"Beaugerie","year":"2013","journal-title":"Dig Dis"},{"key":"key\n\t\t\t\t20180305101522_CIT0074","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","article-title":"Epidemiology of breast cancer","volume":"2","author":"Key","year":"2001","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180305101522_CIT0075","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/ijc.23446","article-title":"Risk factors for invasive squamous cell carcinoma of the vulva and vagina\u2013population-based case-control study in denmark","volume":"122","author":"Madsen","year":"2008","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180305101522_CIT0076","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.ejca.2014.07.018","article-title":"Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples","volume":"50","author":"Alemany","year":"2014","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t20180305101522_CIT0077","article-title":"Endometrial cancer","author":"Morice","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180305101522_CIT0078","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2011.10.009","article-title":"The epidemiology of endometrial and ovarian cancer","volume":"26","author":"Cramer","year":"2012","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/24\/3\/510\/24250534\/izx062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T15:15:43Z","timestamp":1520262943000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/24\/3\/510\/4863709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,16]]},"references-count":78,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,2,16]]},"published-print":{"date-parts":[[2018,2,16]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izx062","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2018,2,16]]}}}